                         SEQUENCE LISTING

<110>  The Johns Hopkins University
 
<120>  COMPOSITIONS AND METHODS FOR RETARGETING VIRUS CONSTRUCTS

<130>  C11155_P11155-02

<150>  61/359,449
<151>  2010-06-29

<160>  44    

<170>  PatentIn version 3.5

<210>  1
<211>  35
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer BFB-1 for site mutation Y477A in adenovirus

<400>  1
cttcctggac ccagaagctt ggaactttag aaatg                                  35


<210>  2
<211>  35
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Primer BFB-2 for site mutation Y477A in adenovirus

<400>  2
catttctaaa gttccaagct tctgggtcca ggaag                                  35


<210>  3
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  M13 forward primer

<400>  3
gtaaaacgac ggccagt                                                      17


<210>  4
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  M13 reverse primer

<400>  4
ggaaacagct atgaccatg                                                    19


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Fiber-S2 primer

<400>  5
ctcaccccct ctaactactg                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Fiber-S3 primer

<400>  6
caggagatgg gcttgaattt                                                   20


<210>  7
<211>  96
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  oligonucleotide library template 5' biotin primer


<220>
<221>  misc_feature
<222>  (1)..(96)
<223>  n=a, g, c or t

<220>
<221>  misc_feature
<222>  (1)..(96)
<223>  m=c or a

<400>  7
tggagttgtg tctccggamn nmnnmnncag tgttgcccag tggtgtgcgg tatcaggctg       60

ccamnnmnnm nngaattcgg attcctgtgt accgct                                 96


<210>  8
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Extension primer Lib001  5' Biotin

<400>  8
agcggtacag gaatcc                                                       16


<210>  9
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide

<400>  9

Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu 
1               5                   10          


<210>  10
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  10

Met Ala Glu Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Asp Pro 
        


<210>  11
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  11

Pro Thr Pro Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Thr Arg 
        


<210>  12
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  12

Pro Met Asn Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Ile 
1               5                   10                  15      


Thr Asp 
        


<210>  13
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  13

Ser Pro Ala Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Ser 
1               5                   10                  15      


Ser His 
        


<210>  14
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  14

Pro Pro Pro Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Asn Ile 
        


<210>  15
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  15

Pro Glu Thr Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Gly 
1               5                   10                  15      


Thr Pro 
        


<210>  16
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  16

Tyr Lys Pro Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Ser 
1               5                   10                  15      


His Gln 
        


<210>  17
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  17

Ser Pro Arg Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Thr 
1               5                   10                  15      


Ser Pro 
        


<210>  18
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  18

Thr Arg Pro Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


His Thr 
        


<210>  19
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  19

Thr Ser Pro Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Ser 
1               5                   10                  15      


Lys Arg 
        


<210>  20
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  20

Asp Lys Met Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu His 
1               5                   10                  15      


Pro Phe 
        


<210>  21
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  21

Asn Ser Arg Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Thr 
1               5                   10                  15      


Thr Arg 
        


<210>  22
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  22

Pro Ser Thr Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


His Leu 
        


<210>  23
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  23

Pro Ser Leu Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Tyr 
1               5                   10                  15      


Pro Met 
        


<210>  24
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  24

Leu Ala Pro Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Thr 
1               5                   10                  15      


Asp Thr 
        


<210>  25
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  25

Thr Ser Asn Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Ala 
1               5                   10                  15      


Cys Thr 
        


<210>  26
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  26

Asn Pro Ser Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Lys 
1               5                   10                  15      


Asn Gln 
        


<210>  27
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  27

Pro Thr Asn Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Met 
1               5                   10                  15      


Pro Ser 
        


<210>  28
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  28

Ser Asn Tyr Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Asn 
    


<210>  29
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  29

Cys Thr Asn Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Lys 
1               5                   10                  15      


Asp Ser 
        


<210>  30
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  30

Tyr Asn Ser Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Thr Ala 
        


<210>  31
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  31

Thr Arg Glu Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Asp 
1               5                   10                  15      


Ser Ser 
        


<210>  32
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  32

Gly Gln Ser Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Glu 
1               5                   10                  15      


Glu Thr 
        


<210>  33
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  33

Ser Gly Val Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Lys 
1               5                   10                  15      


Thr Pro 
        


<210>  34
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  34

Ala Gly Asp Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Lys 
1               5                   10                  15      


Ala Asp 
        


<210>  35
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  35

Ser Gln Thr Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Trp Pro 
        


<210>  36
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  36

Gly Gly Pro Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Asn Ser 
        


<210>  37
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  37

Val His Arg Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Asn 
1               5                   10                  15      


Arg Gln 
        


<210>  38
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  38

Pro Pro Lys Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Pro Pro 
        


<210>  39
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  39

Leu Pro Thr Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Asp 
1               5                   10                  15      


Ser Glu 
        


<210>  40
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  40

Pro Asn Val Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Tyr Pro 
        


<210>  41
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  41

Glu Pro Cys Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Glu Ile 
        


<210>  42
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  42

Ala Lys Asp Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Asp 
1               5                   10                  15      


Asn Val 
        


<210>  43
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  43

Pro Ala Ser Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Gln Arg 
        


<210>  44
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PSMA-targeting peptide flanked by 3 random amino acid cassettes

<400>  44

Pro Arg Pro Trp Gln Pro Asp Thr Ala His His Trp Ala Thr Leu Pro 
1               5                   10                  15      


Arg Gln 
        


